Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

Please contact us at US.corporatecommunications@takeda.com or (224) 554-5499.

Recent News Releases

December 15, 2020 12/15/2020

U.S. Food and Drug Administration Accepts New Drug Application for Review, Grants Priority Review for Takeda’s
TAK-721 (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis

December 2, 2020 12/2/2020

TAKEDA FURTHER ENABLES HEMOPHILIA A PERSONALIZED CARE WITH LAUNCH OF MYPKFIT® SOFTWARE FOR ADYNOVATE ® [ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED]

November 9, 2020 11/9/2020

Takeda to Highlight Research Commitment in Bleeding Disorders and Personalized Care at American Society of Hematology (ASH) Virtual Annual Meeting

October 27, 2020 10/27/2020

Takeda to Present Rare Bleeding Disorders Research at Thrombosis & Hemostasis Summit of North America (THSNA) 2020

August 10, 2020 8/10/2020

National Hemophilia Foundation and Takeda Partner with Alex Borstein to Raise Awareness of von Willebrand Disease

SEE ALL NEWS AND RELEASES >